Page 52 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer
P. 52

Key Question 1. How have the patient population and the natural history of
               prostate cancer diagnosed in the United States changed in the last 30
               years?
                   Prostate cancer epidemiology is affected by population-level trends, such as the aging of the
               United States population, but also by changes in the application of screening and diagnostic
               technologies among the population at risk. To assess temporal trends in the incidence,
               mortality/survival, disease features at diagnosis, and treatment patterns we performed a search to
               identify large studies (≥1000 men) utilizing databases sourced from the U.S. population that
               provided information stratified by factors relevant to Key Question 1 (see the end of the
               Introduction for the list of factors). We also reviewed the latest version of the Cancer Statistics
                                                                                                           2
                                                                       1
               report prepared annually by the American Cancer Society , a recent SEER Survival Monograph ,
                                                                         3
               the 2009/2010 update of the Cancer Trends Progress Report , and data available on the SEER
                         a
               Web site.
                   We identified 79 primary observational studies and one systematic review eligible for
               inclusion in Key Question 1. 4,5,16-92
                   Of the primary observational studies, 51 analyzed the Surveillance Epidemiology and End
               Results (SEER) database of the National Cancer Institute (NCI) or a subset of its component
               registries, nine additional studies utilized the linked SEER-Medicare database, 11 the Cancer of
               the Prostate Urologic Research Endeavor (CaPSURE) database, five the National Cancer
               Database (NCDB), and three analyzed other large U.S.-based databases.
                   •  The SEER database consists of a coordinated system of population-based cancer
                       registries covering geographic areas selected for inclusion based on their ability to
                       provide high quality population-based cancer reporting and for their epidemiologically
                       significant population subgroups. The SEER population is comparable to the general U.S.
                       population with regard to measures of poverty and education; however, the SEER
                       population tends to be somewhat more urban and has a higher proportion of foreign-born
                                                              b
                       persons than the general U.S. population.
                   •  The racial and age distribution on SEER areas is also not perfectly representative of the
                       total U.S. population and the data may be insufficient for minority groups other than
                       blacks. 93,94
                   •  The SEER-Medicare database linked the SEER cancer registries data and Medicare
                                                 c
                       enrollment and claims files.
                   •  A comparison of sociodemographic characteristics of Medicare beneficiaries residing in
                       the SEER areas versus the general U.S. elderly population demonstrated that the age and
                       sex distribution for individuals 65 years and older in the SEER areas was comparable to
                       that of the U.S. elderly population. However, the elderly population in the SEER areas
                       had a lower proportion of whites and a higher proportion of other racial/ethnic groups and
                       was also more likely to reside in an urban setting compared with the average 65 years and
                                            95
                       older U.S. population.
                   •  The CaPSURE database includes data from a longitudinal, observational study of over
                       14,000 men with all stages of biopsy-proven prostate cancer. Patients are enrolled
                       regardless of age, stage of disease, or intended treatment plan. Currently, CaPSURE


               a  Available at http://seer.cancer.gov/faststats/; last accessed September 30, 2011.
               b  http://seer.cancer.gov/registries/characteristics.html ; last accessed September 30, 2011.
               c  See http://healthservices.cancer.gov/seermedicare/; last accessed September 30, 2011.



                                                             17
   47   48   49   50   51   52   53   54   55   56   57